JamesAaronGranthamMD

PubMed

• 13 citations
  Association of Successful Percutaneous Revascularization of Chronic Total Occlusions With Quality of Life: A Systematic Review and Meta-Analysis.
  Selcuk Kucukseymen, Mario Iannaccone, James A Grantham, James Sapontis, Stefan Juricic
  JAMA Network Open. 2023-07-03
• 5 citations
  Hospital-Level Variability in Use of Intracoronary Imaging for Percutaneous Coronary Intervention in the United States.
  Ali O Malik, John T Saxon, John A Spertus, Adam Salisbury, James A Grantham
  Journal of the Society for Cardiovascular Angiography & Interventions. 2023-05-19
• 3 citations
  External validation of the PROGRESS-CTO complication risk scores: Individual patient data pooled analysis of 3 registries.
  Bahadir Simsek, Peter Tajti, Mauro Carlino, Soledad Ojeda, Manuel Pan
  International Journal of Cardiology. 2023-03-15

Journal Articles

• Coronary Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights from the OPEN-CTO Re...  
  David J Cohen, Sophia Airhart, J Aaron Grantham, Adam C Salisbury, James M McCabe, John A Spertus, ScienceDirect

Books/Book Chapters

• Heart Diseases 
  Chapter: The OAT Trial in Perspective: When is Chronic Total Occlusion Angioplasty Clinically Indicated? 
  Grantham JA, Rutherford BDEditors: Eugene Braunwald.Elsevier Inc.Edition 8th,2008
• Restenosis: A Therapeutic Guide 
  Chapter: Stenting to Prevent Restenosis 
  Grantham JA, Holmes DR, Jr.Editors: David P. Faxon.Martin Dunitz Ltd.2001
• Contemporary Endocrinology Series, 5. Natriuretic Peptides in Health and Disease 
  Chapter: The Natriuretic Peptides in Cardiovascular Disease: A Focus on Congestive Heart Failure 
  Grantham JA, Burnett JC, JrEditors: W.K. Samson and E.R. Levins.Totowa Press Inc.1997

Abstracts/Posters

• Health status benefits of angioplasty for chronic total occlusions: An analysis from the OPA/PRISM studies
  Safley DS, Grantham JA, Jones PA, Spertus J, J Am Coll Cardiol, 1/1/2012
• Current Practice Patterns in Percutaneous Treatment of Chronic Total Occlusions and the Association of Operator Volume With Treatment
  Grantham JA, Spertus JA, Circulation, 5/29/2007
• Intermediate Volume Operators Attempt Percutaneous Coronary Intervention (PCI) of Chronic Total Occlusions (CTO) More Frequently than Low or High Volume Operators: An ...
  Grantham JA, Spertus JA, Kosiborod M, Safley DM, and Marso SP, J Am Coll Cardiol, 3/1/2007
• Improvement in Survival Following Successful Angioplasty of Coronary Chronic Total Occlusions: Variability by Target Vessel
  Safley D, House J, Marso SP, Grantham JA, Rutherford BD, Am J Cardiol, 10/1/2006
• Elective Percutaneous Coronary Intervention is Safe without Onsite Cardiac Surgical Back-up
  Menon P, Stoner C, House J, Safley DM, Barberena J, Grantham JA, Marso S, Am J Cardiol, 10/1/2006
• Culprit vs. Complete Revascularization in Acute Myocardial Infarction Patients with Multivessel Coronary Artery Disease: Effects on Health Status and Clinical Outcomes
  Grantham JA, Cohen DJ, Kosiborod M, Safley DM, Reid K, Bach RM, Curtis J, Khanal S, Rutherford BD, Spertus J, Circulation, 5/1/2006
• Using the Risk of Restenosis as a Guide to Triaging Patients Between Surgical and Percutaneous Coronary Revascularization
  Kettelkamp R; House J, Mukesh MS; Garg S, Scott R; Grantham JA; Spertus J, Circulation, 1/1/2004
• Multivessel Percutaneous Coronary Revascularization Early After Acute Myocardial Infarction
  Grantham JA, Berger PB, Velianou JL, Lennon RJ, and Rihal CS, Circulation, 1/1/2000
• HMGCoA Reductase Inhibition Attenuates Vascular Endothelin-1 Generation in Experimental Atherosclerosis
  Grantham JA, Rajamannan NM, Burnett JC, Jr, Circulation, 1/1/1999
• Enhanced Endothelin-Converting Enzyme Immunoreactivity in Early Atherosclerosis
  Grantham JA, Schirger, JA, Williamson, EE, Wennberg, PW, Kirchengast, M, Meunter, K, Subkowski, T, and Burnett, JC, Jr, Cardiovasc Pharmacol, 1/1/1998
• Chronic Endothelin Type A Receptor Antagonism in experimental Heart Failure
  Borgeson DD, Grantham JA, Williamson EE, Luchner A, Redfield MM, Opgenorth TJ, Burnett JC, Jr, Hypertension, 1/1/1998
• The Use of Abciximab in Aortocoronary Vein Graft Interventions
  Mathew V, Grantham JA, Grill DE, Ting HH, Holmes DR, Jr, Circulation, 1/1/1998
• Antiproliferative and Vasodilating Actions of BNP: Modulation by Atherosclerosis and NEP Inhibition
  Schirger JA, Grantham JA, Wennberg PW, Chen HH, Lisy O, Miller VM, Simari RD, Burnett JC, Jr, Circulation, 1/1/1998
• Subcutaneous BNP in Experimental Mild Heart Failure: A Novel Therapeutic Strategy
  Chen HH, Grantham JA, Schirger JA, Lisy O, Redfield MM, Jougasaki M, Burnett JC, Jr, Circulation, 1/1/1998
• Antiplatelet therapy with Abciximab for Percutaneous Intervention of Thrombus-Laden Bypass Grafts
  Grantham JA, Mathew V, and Holmes Dr, Jr, Circulation, 1/1/1998
• Functionally Active ECE emerges in the Vascular Wall in Atherosclerosis and is Inhibited by Chronic Neutral Endopeptidase Inhibition
  Grantham JA, Schirger JA, Kirchengast M, Meunter K, Subkowski T, and Burnett JC, Jr, ourth Annual Astra-Merck Young Investigators Competition, Squaw Creek, NV, 1/1/1998
• Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Acute Myocardial Infraction: A Retrospective Analysis of In Hospital and One Year Outcomes
  Grantham JA, Hasdai D, Kopecky SR, and Holmes DR, Jr, JACC, 1/1/1998
• Regulation of Tissue ET-1 by ECE and Tissue Peptidases in Early Atherosclerosis
  Grantham JA, Schirger JA, Williamson EE, Wennberg PW, Kirchengast M, Meunter K, Subkowski T, Burnett JC, Jr, Fifth International Conference on Endothelin, Kyoto, Japan, 9/13/1997
• Attenuated Glomerular Accumulation of cGMP in Experimental Atherosclerosis
  Chau WL, Schirger JA, Grantham JA, Grande JP, and Burnett JC, Jr, J Am Soc Nephrol, 1/1/1997
• Neutral Endopeptidase Inhibition in Acute Heart Failure Offsets Activation and Na Retention Induced by Chronic Furosemide
  Wentling GK, Grantham JA, Barclay PL, Burnett JC, Jr, Circulation, 1/1/1997
• Enhanced Neurohumoral Activation and Sodium Retention in Acute Heart Failure after Chronic Furosemide is Attenuated by Acute Neutral Endopeptidase Inhibition
  Wentling GK, Grantham JA, Barclay P, Burnett JC, Jr, Heart Failure, Cologne, Germany, 1/1/1997
• Cardiorenal and Neurohumoral Responses to Chronic ET-A Receptor Antagonism in Experimental CHF
  Borgeson DD, Grantham JA, Luchner A, Redfield MM, Opgenorth TJ, Burnett JC, Jr, Heart Failure, Cologne, Germany, 1/1/1997
• Chronic ACE Inhibition Improves Renal Hemodynamics but not Sodium Homeostasis in Progressive CHF: Relationship to Impaired Natriuretic Peptide Release
  Grantham JA, Borgeson DD, Stevens TL, Redfield MM, Burnett JC, Jr, Heart Failure, Cologne, Germany, 1/1/1997
• Differential Regulations of ANP and BNP Synthesis and Release by Angiotensin II in Congestive Heart Failure
  Sandberg SM, Grantham JA, Luchner A, Borgeson DD, Stevens TL, Burnett JC, Jr, Heart Failure, Cologne, Germany, 1/1/1997
• Deleterious Actions of Dietary Sodium Restriction Upon the Progression of Experimental Congestive Heart Failure
  orgeson DD, Stevens TL, Grantham JA, Luchner A, Redfield MM, Burnett JC, Jr, JACC, 1/1/1997
• Join now to see all

Lectures

• Higher Risk Higher Reward 
  2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
• Future Hub: TelePCI: At the Edge of the Playing Field 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Interventional Live Case Session VI: Coronary Transmission from University of Washington Medical Center 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Chronic Total Occlusion: The Final Frontier is Settled 
  Chicago, IL (2013); Pittsburgh, PA (2014) - 1/1/2014
• CTO-PCI is it worth the time? and CTO-PCI retrograde techniques 
  9/1/2007
• Principles and Perspectives in Interventional Cardiology 
  Kona-Kohala Coast, Big Island, HI - 7/1/2007
• Join now to see all